Faye Wu is a dedicated research scientist with extensive experience in developing strategies for in-vitro and in-vivo assays across various biopharmaceutical companies. Beginning a career in 1999 at Bayer, Faye has progressively advanced through roles from Associate Scientist to Staff Scientist, contributing to multiple drug discovery programs and leading significant projects in gene therapy and chimeric antigen receptor (CAR) T cells. Notable positions include Senior Associate Scientist at Dynavax Technologies and Research Scientist at NGM Biopharmaceuticals, where Faye was instrumental in establishing functional assays and optimizing candidate selection. Currently, Faye is engaged with Bayer, focusing on advancing CAR T programs and optimizing protein quantitation assays for hemophilia treatment. Education was completed at the University of California, Davis.
This person is not in the org chart
This person is not in any teams
This person is not in any offices